|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.69 USD | -0.73% |
|
+0.66% | +5.40% |
| 07-30 | Drugmakers, retailers must face 'maximum strength' claim in decongestant false ad litigation in US | RE |
| 07-30 | GSK global supply chain director sells 38,000 shares | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC | Other Pharmaceuticals | -0.73% | +0.66% | +5.40% | +37.62% | +3.02% | 104B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
- Charts GSK plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
